#tofacitinib
Live, measured metrics for the hashtag #tofacitinib from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #tofacitinib
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mastodon.social (Mastodon public tags API) · fetched 2026-09-25 17:51 UTCNo measured public usage for #tofacitinib in the last 7 days. That is a real result, and a good one to know: this hashtag is wide open right now. We show a dash before we ever show a made-up number. Browse the trending index for tags with live measurements.
Related hashtags
measured · mastodon.social (Mastodon public search API) · fetched 2026-09-25 17:51 UTCNo related tags with measured usage found for #tofacitinib.
Live pulse
measured · Mastodon tag timeline · fetched 2026-09-25 17:51 UTCNo recent public posts found for #tofacitinib on Mastodon. Nothing measured, so nothing shown.
What “tofacitinib” means
WikipediaTofacitinib, sold under the brand Xeljanz, Neojanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular-course juvenile idiopathic arthritis, and ulcerative colitis. It is a janus kinase (JAK) inhibitor, discovered and developed by the National Institutes of Health and Pfizer.
“Tofacitinib” on Wikipedia (CC BY-SA) →#tofacitinib across platforms
every network with a public tag surfaceFollow #tofacitinib straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/tofacitinib